18F-FDG PET-CT scanning and diabetic patients

Abstract

We conclude that scheduling for F-FDG PET-CT can be performed efficiently using simple preparation instructions, even in the context of high prevalence of DM and with a high rate of incidental diagnosis of DM at the time of scanning.

Is the measurement of the size of uterine lesions with positron emission tomography consistent in pre- and postmenopausal periods in endometrioid-type endometrial cancer?

“…In our cohort, we found that there were statistically significantly more patients with diabetes among the postmenopausal patients (p=0.005). However, previous studies reported that PET/CT could be applied to diabetics ( 15 ) . In all patients (diabetics and non-diabetics), the serum glucose levels measured before 18 F-FDG injections were found to be less than 140 mg/dL.…”

Hounsfield units and fractal dimension (test HUFRA) for determining PET positive/negative lymph nodes in pediatric Hodgkin’s lymphoma patients

“…Currently, only few contradictions for 18F-FDG-PET/CT exist. The reliable result can be obtained when the patients are properly prepared for the examination, even in the cases combined with diabetes or other endocrine diseases, affecting carbohydrate metabolism [40]. The HUFRA test may be also useful in patients with unstable blood glucose values, before 18F-FDG-PET/CT examination or in cases suspicious for patient glycemic status, which may influence the result of this examination.…”